After the Ablation: StimCardio, Wearable Neuromodulation and the Next AF Outcome Gap
Dr. Dereck Mush, MD, MBA
Mainstay Medical
Implantable neurostimulation systems for treating chronic low back pain.
What they do
The company manufactures an active implantable restorative neurostimulation device designed to treat chronic low back pain by rehabilitating the multifidus muscle. Pain specialists and spine surgeons purchase this therapy for patients who have failed conservative treatment.
The record
- Vertical
- Medical Devices
- Sub-segment
- Neuromodulation
- Product type
- Device
- Stage
- Growth
- Headquarters
- Dublin, Ireland
- Region
- Europe
- Founded
- 2008
- Total funding
- $230M raised
Notable investors: Sofinnova Partners, Fountain Healthcare Partners, Capricorn Partners.
Also in Medical Devices
Related on The Signal
Dr. Dereck Mush, MD, MBA
Next-Gen Neurotechnologies: Graphene Electrodes and Magnetic Surgical Robotics in Deep Brain Neuromodulation
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
The 8 Most Innovative MedTech Devices Right Now
From a pacemaker the size of a vitamin to a scanner that books its own follow-up, these are the devices actually changing care in 2026.
Dr. Dereck Mush, MD, MBA